Kinase domain mutants of Bcr-Abl exhibit altered transformation potency, kinase activity, and substrate utilization, irrespective of sensitivity to imatinib.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples